mRNA vaccines: a new era in vaccine development
Oncology Research · 2024 · 32 (10) · 1543-1564
DOI: 10.32604/or.2024.043987 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research, 2024. Verfasst von Shubhra Chandra und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia. Hauptthemen laut MEDLINE: mRNA Vaccines, Cancer Vaccines, Neoplasms, Vaccine Development. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy & Medical Sciences, Gold Coast campus, Griffith University, Brisbane, QLD-4222, Australia.
- Menzies Health Institute Queensland (MHIQ), Gold Coast Campus, Griffith University, Brisbane, QLD-4215, Australia.
- School of Allied Health, Australian Catholic University, Brisbane, QLD-4014, Australia.
Zitieren
APA
Chandra, S., Wilson, J. C., Good, D., & Wei, M. Q. (2024). mRNA vaccines: a new era in vaccine development. Oncology Research, 32(10), 1543-1564. https://doi.org/10.32604/or.2024.043987
Vancouver
Chandra S, Wilson JC, Good D, Wei MQ. mRNA vaccines: a new era in vaccine development. Oncology Research. 2024;32(10):1543-1564. doi:10.32604/or.2024.043987
BibTeX
@article{Chandra2024,
author = {Chandra, Shubhra and Wilson, Jennifer C and Good, David and Wei, Ming Q},
title = {mRNA vaccines: a new era in vaccine development},
journal = {Oncology Research},
year = {2024},
volume = {32},
number = {10},
pages = {1543--1564},
doi = {10.32604/or.2024.043987}
}
EUVIMED